For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
Presenting this year's finalists
Wednesday 29 January 2020, 04:00 AM

Forty-two entrants to the first-ever national primary healthcare awards are excited to find out they are in to win an award. And in the event they don’t win, they can hold their heads high as finalists. There were close to 180 entrants to the awards, which closed last November.
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.